A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes

Clinical trial NCT03560271 · COMPLETED

Trial details

NCT number: NCT03560271
Sponsor: NovMetaPharma Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2018-06-18
Primary completion: 2019-06-25
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.